日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Management of malignant struma ovarii: is aggressive therapy justified? Case report and literature review

卵巢恶性甲状腺肿的治疗：积极治疗是否合理？病例报告及文献综述

期刊:Thyroid Research
影响因子:1.8
doi:10.1186/s13044-022-00132-6
Leuștean, Letiția; Ungureanu, Maria-Christina; Preda, Cristina; Bilha, Stefana Catalina; Obrocea, Florin; Dănilă, Radu; Stătescu, Laura; Apostol Ciobanu, Delia Gabriela
免疫/内分泌
发表日期：2022
文献求助 收藏

Cancer vaccines at an inflexion point: what next?

癌症疫苗正处于转折点：接下来会怎样？

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/1479-5876-9-148
Bot, Adrian; Obrocea, Mihail; Marincola, Francesco M
肿瘤
肿瘤免疫
发表日期：2011
文献求助 收藏

A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors

一项针对黑色素瘤中优先表达的抗原和前列腺特异性膜抗原的疫苗在晚期实体瘤患者中的I期研究

期刊:Journal of Immunotherapy
影响因子:2.9
doi:10.1097/CJI.0b013e3182280db1
Weber, Jeffrey S; Vogelzang, Nicholas J; Ernstoff, Marc S; Goodman, Oscar B; Cranmer, Lee D; Marshall, John L; Miles, Sabrina; Rosario, Dar; Diamond, David C; Qiu, Zhiyong; Obrocea, Mihail; Bot, Adrian
黑色素瘤
发表日期：2011
文献求助 收藏

Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity

程序性死亡受体1 (PD-1) 是异源初免-加强疫苗和CD8+ T细胞免疫调控的核心。

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/1479-5876-8-132
Bot, Adrian; Qiu, Zhiyong; Wong, Raymond; Obrocea, Mihail; Smith, Kent A
T细胞
信号转导
CD8
T细胞
细胞生物学
PD-1
免疫/内分泌
发表日期：2010
文献求助 收藏